| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 05/23/2007 | CN1317277C Benzofuran derivatives and their use as antibacterial agents |
| 05/22/2007 | US7220872 Conversion of taxane molecules |
| 05/22/2007 | US7220871 taxane is prepared by esterifying an appropriate baccatin carrying a C-13 hydroxyl functional group with an acid derivative and is obtained by controlled saponification |
| 05/22/2007 | US7220864 Peroxisome proliferator activator controller; dietetics; antidiabetic agents; cardiovascular disorders; antidiabetic agents; hypoglycemic agents; antilipemic agenst |
| 05/18/2007 | WO2007054105A2 Method for the preparation of escitalopram |
| 05/17/2007 | US20070111991 10,11-Dihydro-dibenzo[b,f]oxepine-10-carboxylic acid [(1S*,2S*,4R*)-4-butylcarbamoyl-2-hydroxy-1-(3-hydroxy-benzyl)-pentyl]-amide; treatment of neurological and vascular disorders related to beta-amyloid generation and/or aggregation |
| 05/16/2007 | EP1784389A1 Process for atorvastatin calcium amorphous |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | CA2236293C Intermediates for the hemisynthesis of taxanes and processes for their preparation |
| 05/10/2007 | US20070106095 Vitamin d receptor modulators |
| 05/10/2007 | US20070105944 Taxane metabolites |
| 05/10/2007 | US20070105913 Alkynyl aryl carboxamides |
| 05/10/2007 | US20070105847 1,3-Dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| 05/10/2007 | US20070105030 1, 4-Benzodioxane sulfonic acid compound and use thereof as electron-acceptor material |
| 05/09/2007 | EP1783127A1 Novel compound having lipase inhibitory activity |
| 05/09/2007 | EP1597238B1 Hiv replication inhibiting pyrimidines and triazines |
| 05/09/2007 | CN1960971A Substituted pyrrolidine-2-ones |
| 05/09/2007 | CN1960721A C7 lactyloxy-substituted taxanes |
| 05/09/2007 | CN1958583A Method for preparing double (N-methyl phthalimide) oxide |
| 05/08/2007 | US7214708 potent inhibitor of tumor cell growth, acting via a microtubule stabilization mechanism; for treating a hyperproliferative disease |
| 05/08/2007 | US7214707 Dimeric compounds and their use as anti-viral agents |
| 05/08/2007 | US7214681 Tri(cyclo) substituted amide compounds |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2182878C Novel cytotoxic macrolides and methods of use |
| 05/03/2007 | WO2007050732A1 INDAZOLE DERIVATIVES THAT INHIBIT TRPVl RECEPTOR |
| 05/03/2007 | US20070099826 Treatment of diseases associated with the egr-1 enhancer element |
| 05/03/2007 | US20070099257 Method for releasing a product comprising chemical oxidation, method for detecting said product and uses thereof |
| 05/03/2007 | CA2626593A1 Indazole derivatives that inhibit trpv1 receptor |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1230238B1 Process for the preparation of fumagillin |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/01/2007 | CA2132131C 3-arylbenzofuranones as stabilisers |
| 04/26/2007 | WO2007046747A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/26/2007 | CA2628577A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/25/2007 | EP1315710B1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 04/25/2007 | CN1312148C Isochroman compounds for treatment of CNS disorders |
| 04/25/2007 | CN1312127C 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 04/24/2007 | US7208495 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof |
| 04/24/2007 | US7208169 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 04/19/2007 | WO2007044729A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 04/19/2007 | WO2007043621A1 Total synthesis of pladienolide b and pladienolide d |
| 04/19/2007 | WO2007042321A2 Kinase inhibitors |
| 04/19/2007 | WO2007041969A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 04/19/2007 | WO2007011629A3 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use |
| 04/19/2007 | WO2006131398A3 Inhibitors of soluble adenylate cyclase |
| 04/19/2007 | US20070088080 Gsk-3 inhibitors isolated from marine organisms |
| 04/19/2007 | CA2623768A1 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 04/19/2007 | CA2623500A1 Kinase inhibitors |
| 04/18/2007 | EP1773853A1 Monophosphine compounds, transition metal complexes thereof and production of optically active compounds using the complexes as asymmetric catalysts |
| 04/18/2007 | EP1773330A2 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 04/18/2007 | EP1394161B1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
| 04/18/2007 | CN1950350A Liquid crystal compound comprising two condensed and substituted rings |
| 04/18/2007 | CN1310910C Hydroxy pyranone derivative and preparation method thereof |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205416 unsubstituted and substituted alpha-methylene lactones by a liquid phase reaction of starting lactones with formaldehyde in the presence of a novel catalyst that exhibits high conversion and selectivity |
| 04/17/2007 | US7205333 Therapy for influenza virus; inhaler |
| 04/17/2007 | US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide |
| 04/17/2007 | US7205317 Pain management |
| 04/17/2007 | CA2272882C Ketone derivatives and their medical applications |
| 04/12/2007 | WO2007039782A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors |
| 04/12/2007 | WO2007039609A1 Pyranodibenzofuran derivatives with antifungal and antibacterial activity |
| 04/12/2007 | WO2006134163A3 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 04/12/2007 | US20070082883 HIV protease inhibitors |
| 04/11/2007 | EP1771430A2 Preparation of alpha-hydroxy and alpha-amino ketones |
| 04/11/2007 | EP1678164B1 Substituted pyrazinone compounds for the treatment of inflammation |
| 04/10/2007 | US7202350 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives, are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 04/04/2007 | CN1942188A Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides |
| 04/04/2007 | CN1939917A Cannabinol derivatives and pharmaceutical use thereof |
| 04/03/2007 | US7199254 Liquid phase synthesis of methylene lactones using novel catalyst |
| 04/03/2007 | US7199127 (2-chloropurin-9-yl)-tetrahydrothiophene-3,4-diols; anticarcinogenic agents selective to A3 adenosine receptors; breast cancer |
| 03/29/2007 | US20070072842 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors |
| 03/28/2007 | EP1765803A1 Quaternary salt ccr2 antagonists |
| 03/28/2007 | EP1765354A1 Leptomycin compounds |
| 03/28/2007 | CN1938279A Modulators of atp-binding cassette transporters |
| 03/28/2007 | CN1938013A Methods and agents for inhibiting dynamin-dependent endocytosis |
| 03/27/2007 | US7196089 Administering to a patient a furan ring containing compound as prostaglandin E4 receptor antagonist to treat various diseases, such as migraines and headache |
| 03/21/2007 | EP1764363A2 Substituted acetophenonederivatives |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1345943B1 Inhibitors of papilloma virus |
| 03/21/2007 | EP1242059B1 Novel prodrugs for antimicrobial amidines |
| 03/21/2007 | CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 03/21/2007 | CN1934101A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 03/21/2007 | CN1933839A Compounds and methods of use |
| 03/21/2007 | CN1931858A Monomer and polymer for photoresist having spirocyclic ketal group, and photoresist composition containing the polymer |
| 03/20/2007 | CA2211320C 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2 |
| 03/14/2007 | EP1761524A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists |
| 03/14/2007 | EP1517895B1 8-(biaryl) quinoline pde4 inhibitors |
| 03/14/2007 | EP1095947B1 Novel antibacterial compounds |
| 03/14/2007 | EP1040103B1 Anilide derivative, production and use thereof |
| 03/14/2007 | CN1930152A 1,3-dioxane derivatives and analogues thereof useful in the treatment of I.A. obesity and diabetes |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | CA2263336C Neuraminic acid compounds |
| 03/08/2007 | WO2007025899A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2620818A1 Amide derivatives as rock inhibitors |
| 03/08/2007 | CA2620688A1 Heterocyclic compound |
| 03/08/2007 | CA2619919A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/07/2007 | CN1925862A Treatment of diseases associated with the EGR-1 enhancer element |